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Abstract
Background: Posttranslational deimination or citrullination by peptidylarginine deiminases (PAD) regulates the biological
function of proteins and may be involved in the development of autoimmune diseases such as rheumatoid arthritis and
multiple sclerosis. This posttranslational modification of arginine was recently discovered on inflammatory chemokines
including CXCL8 and CXCL10, and significantly reduced their biological activity. To evaluate the importance of these
modified chemokines in patients, methods for the detection and quantification of citrullinated chemokines are needed.
Since citrullination only results in an increase of the protein mass with one mass unit and the loss of one positive charge,
selective biochemical detection is difficult. Therefore, we developed an antibody-based method to specifically detect and
quantify citrullination on a protein of interest.
Methodology/Principal Findings: First, the citrullinated proteins were chemically modified with antipyrine and 2,3-
butanedione at low pH. Such selectively modified citrullines were subsequently detected and quantified by specific
antibodies raised against a modified citrulline-containing peptide. The specificity of this two-step procedure was validated
for citrullinated CXCL8 ([Cit
5]CXCL8). Specific detection of [Cit
5]CXCL8 concentrations between 1 and 50 ng/ml was possible,
also in complex samples containing an excess of contaminating proteins. This novel detection method was used to evaluate
the effect of lipopolysaccharide (LPS) on the citrullination of inflammatory chemokines induced in peripheral blood
mononuclear cells (PBMCs) and granulocytes. LPS had no significant effect on the induction of CXCL8 citrullination in
human PBMCs and granulocytes. However, granulocytes, known to contain PAD, were essential for the production of
significant amounts of [Cit
5]CXCL8.
Conclusion/Significance: The newly developed antibody-based method to specifically detect and quantify chemically
modified citrullinated proteins is proven to be effective. This study furthermore demonstrates that granulocytes were
essential to obtain significant levels of [Cit
5]CXCL8. For human PBMCs and granulocytes stimulation with LPS did not affect
the citrullination of CXCL8.
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Introduction
Chemokines are small chemotactic cytokines playing a role in
leukocyte recruitment during leukocyte homeostasis and inflamma-
tion, in tumor development and in angiogenesis [1]. The biological
activity of these proteins depends on the interaction with seven
transmembrane spanning G protein-coupled receptors (GPCR), i.e.
CXC and CC chemokine receptors (CXCR and CCR) [2,3]. In
addition, chemokines bind matrix- or cell-associated glycosamino-
glycans [4]. The cytokine and chemokine activity is regulated at
multiplelevelsincluding posttranslationalmodification (PTM)[5,6].
NH2- and COOH-terminal proteolytic processing and glycosyla-
tion have been detected on chemokines [6]. Depending on the
chemokine and on the type of PTM, reduced or enhanced receptor
affinityor specificity and chemokine activity have been reported [7].
In addition to truncation and glycosylation, deimination of
arginine (Arg) to citrulline (Cit) or citrullination is a recently
discovered PTM on chemokines [8,9]. The enzymes responsible
for the conversion of peptidylarginine to peptidylcitrulline are
peptidylarginine deiminases (PAD) [10]. Citrullination of proteins
may seriously influence the organization of the protein structure
and interactions in macromolecules, resulting in altered protein
folding [11,12]. Moreover, citrullinated proteins and autoantibod-
ies to citrullinated peptides have been implicated in autoimmune
diseases such as rheumatoid arthritis [13,14] and multiple sclerosis
[15].
Natural citrullination of the inflammatory chemokines interleu-
kin-8 (IL-8/CXCL8) and interferon-induced protein-10 (IP-10/
CXCL10) occurs specifically on arginine residue 5 [8,9]. In
contrast, multiple arginines (arginine 8, 12, 20, 41 and 47) in
stromal cell-derived factor-1a (SDF-1a/CXCL12) are rapidly
deiminated upon incubation with PAD [16]. For the chemokines
epithelial cell-derived neutrophil-activating protein-78 (ENA-78/
CXCL5), CXCL8, CXCL10, interferon T cell a-chemoattractant
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significantly alters the biological activity [8,9,16–18]. Indeed,
several protein-protein interactions, e.g. chemokine-enzyme or
chemokine-receptor, and protein-glycosaminoglycans (GAG) in-
teractions, such as heparin and heparan-sulphate, are affected.
Although citrullination of CXCL8 has a minor effect on its affinity
for CXCR1 or CXCR2, the binding of citrullinated CXCL8 to
erythrocytes expressing the atypic Duffy antigen/receptor for
chemokines (DARC) is significantly weakened [8,18]. For
CXCL12, citrullination of arginine 8 only, results in significantly
reduced affinity for CXCR4, but not for CXCR7. However
further citrullination reduces and even impedes the CXCR4 and
CXCR7-binding capacities [16]. Deimination of CXCL10 and
CXCL11 hardly affects their affinity for CXCR3 or CXCR7 [9].
The chemokine-GAG interactions are reduced upon citrullination
of CXCL8, CXCL10 and CXCL11 [8,9]. Moreover citrullination
of intact CXCL8(1–77) protects this chemokine from being
cleaved by the serine proteases thrombin and plasmin into the
more potent 72 amino acid form [8]. All these weakened
molecular interactions result in reduced in vitro activity (e.g.
signalling, adhesion molecule expression, chemotaxis) for CXCL5,
CXCL8, CXCL10, CXCL11 and CXCL12. More strickingly,
citrullinated CXCL8 is unable to induce neutrophil extravasation
to the peritoneal cavity in vivo. These studies clearly show the
biological importance of the citrullination of chemokines.
Inflammatory chemokines are primarily produced upon stim-
ulation of cells with cytokines or microbial products such as Toll-
like receptor (TLR) ligands [2]. CXCL8, the main human
neutrophil chemotactic protein, is produced in large amounts by
neutrophils and peripheral blood mononuclear cells (PBMCs)
upon bacterial infection [19–21]. However, no information is
available on the levels of citrullinated chemokine produced by
these cells.
PTMs such as NH2- and COOH-terminal truncations and
glycosylation of chemokines which result in a significant alteration
of the molecular mass were already successfully identified by mass
spectrometry [22,23]. However, citrullination of chemokines and
cytokines results in an increase of only one mass unit and the loss
of one positive charge. This minor change in relative molecular
mass (Mr) is difficult to detect by mass spectrometry. Here we
describe a technique for the specific chemical labeling, immuno-
biological detection and quantification of citrullinated CXCL8
([Cit
5]CXCL8). Citrullinated proteins are detected and quantified
by means of antibodies raised against this chemically modified
citrulline. To investigate whether TLR ligands and the presence of
granulocytes also influence the citrullination of inflammatory
chemokines, we evaluated the absolute amounts of [Cit
5]CXCL8
in human PBMCs and granulocytes upon stimulation with an
important TLR ligand, i.e. lipopolysaccharide (LPS).
Materials and Methods
Ethics statement
No specific approval from an institutional review board is
required for the use of buffy coats for the following reasons: (1) no
personal patient information is made available, (2) buffy coats
cannot be used for treatment of patients and are therefore waste
products for the blood transfusion centre and (3) blood donors sign
an agreement that parts of the donation that cannot be used for
patient treatment may be used for scientific research.
Reagents and materials
Bacterial LPS, antipyrine, 2,3-butanedione (.99.4% [GC]) and
keyhole limpet hemocyanin (KLH) were obtained from Sigma-
Aldrich (St Louis, MO, USA) and 1-ethyl-3-(3-dimethylamino-
propyl) carbodiimide (EDC) from Pierce (Rockford, IL, USA).
Fetal bovine serum (FBS) was purchased from HyClone (Rock-
ford, IL, USA) and RPMI 1640 medium from Lonza (Basel,
Switzerland). Samples of human blood, serum and plasma were
obtained from healthy volunteers. Chemokines (CXCL8,
[Cit
5]CXCL8 and [Cit
9]CXCL5) were chemically synthesized
in-house by solid phase peptide synthesis [17,24].
Synthesis and chemical modification of citrulline-
containing peptides
Peptides were chemically synthesized based on fluorenyl
methoxycarbonyl (Fmoc) chemistry using a 433A solid phase
peptide synthesizer (Applied Biosystems, Foster City, CA, USA), as
described by Loos et al. [24]. Following synthesis, the resin and the
side chain protecting groups were cleaved from the synthetic
peptides with a mixture of 9.5 ml trifluoroacetic acid (TFA) and
0.5 ml water for 90 min at room temperature. The resin particles
were removed by filtering the TFA solution through a Biospin
filter (Bio-Rad laboratories, Hercules, CA, USA). The peptides in
the filtrate were precipitated and washed with cold diethyl ether,
dissolved in water, lyophilized, re-dissolved in 0.1% (v/v) TFA and
purified by RP-HPLC on a 4.66150 mm Source 5RPC column
(GE Healthcare, Diegem, Belgium) applying an acetonitrile
gradient in 0.1% TFA. UV absorption was monitored at
220 nm. Part of the column effluent (0.7%) was analyzed by
online ion trap mass spectrometry (Esquire LC; Bruker Daltonics,
Bremen, Germany). HPLC fractions containing the synthetic
peptides were lyophilized and pooled in ultrapure water and
chemically modified by adding 25 mM antipyrine, 16% TFA and
6.25 mM 2,3-butanedione, as previously described [25,26]. The
mixture was incubated for 2 h at 37uC in the dark, diluted with
ultrapure water and repurified on a 4.66150 mm Source 5RPC
column applying an acetonitrile gradient in 0.1% TFA and
detected at 220 nm. Part of the column effluent (0.7%) was
analyzed by online ion trap mass spectrometry (Esquire LC,
Bruker Daltonics). Fractions containing the peptide with correct
Mr were pooled, lyophilized and dissolved in ultrapure water
(MilliQ; Millipore, Billerica, MA, USA). The peptide sequences
and concentrations were determined by Edman degradation on a
491 Procise cLC protein sequencer (Applied Biosystems).
Antibody production and purification
2 mg chemically modified synthetic peptide and 2 mg KLH
were dissolved in 50 mM MES (2-[N-morfolino]ethane sulfonic
acid) buffer (pH 5). 50 mL of 50 mM EDC was added and the
resulting mixture incubated for 2 h at room temperature. The
immunogen was injected intramuscularly in a New Zealand white
rabbit (Oryctolagus cuniculus) and blood samples were collected from
the ear veins 8 to 20 days after immunization. Serum was filtered
and antibodies were purified by affinity chromatography on a
Protein G Sepharose column (GE Healthcare). Collected elutions
were analyzed by enzyme-linked immunosorbent assay (ELISA) to
verify the presence of specific antibodies against chemically
modified citrulline residues.
Detection of total CXCL8
The level of total human CXCL8 was quantified by a specific
sandwich ELISA as previously described [27]. A 96-well plate was
coated with goat polyclonal anti-human CXCL8 antibody
generated in our laboratory [28], followed by blocking with
phosphate buffered saline (PBS) containing 0.1% (w/v) casein and
0.05% (v/v) Tween 20. Total human CXCL8 in samples was
Quantification of Citrullinated CXCL8
PLoS ONE | www.plosone.org 2 December 2011 | Volume 6 | Issue 12 | e28976detected by mouse monoclonal anti-human CXCL8 antibody
(R&D Systems, Abingdon, UK) and by a secondary peroxidase-
conjugated anti-mouse IgG antibody (Jackson ImmunoResearch
Laboratories, West Grove, PA, USA). Peroxidase activity was
quantified by measuring the conversion of 3,39,5,59-tetramethyl-
benzidine (TMB) (Sigma-Aldrich) at 450 nm.
Detection of citrullinated CXCL8
The procedure to chemically modify and detect a citrulline-
containing protein of interest is shown in Figure 1. Peptidylcitrul-
line residues in samples were chemically modified by addition of
50 mM antipyrine, 16% TFA and 12.5 mM 2,3-butanedione [25]
and incubation for 2 h at 37uC in the dark. The strongly acidic
reaction mixture was dialyzed against PBS containing 0.05%
Tween 20 (pH7.4) overnight at room temperature and protected
from light using Slide-A-LyzerHMINI Dialyse Units (Pierce).
To detect citrullinated CXCL8, a specific sandwich ELISA was
developed. A 96-well plate was coated with mouse monoclonal
anti-human CXCL8 antibody (R&D Systems), followed by
blocking with PBS containing 0.1% casein and 0.05% Tween
20. Human [Cit
5]CXCL8 in chemically modified samples was
detected by the specific rabbit antibodies against chemically
modified citrulline residues and by a secondary peroxidase-
conjugated anti-rabbit IgG antibody (Jackson ImmunoResearch
Laboratories) (Figure 1). Peroxidase activity was quantified by
measuring the conversion of TMB at 450 nm.
Cell cultures and induction experiments
PBMCs and granulocytes were isolated from human buffy coats
(blood transfusion center of the Red Cross, Leuven, Belgium) as
previously described [18,29]. PBMCs and granulocytes were
separated by density gradient centrifugation on Ficoll-sodium
diatrizoate (Lymphoprep; Axis-Shield PoC AS, Oslo, Norway) for
30 min at 400 g. PBMCs and granulocytes were obtained from
the supernatant and pellet, respectively. Erythrocytes in the
granulocyte pellet were removed by sedimentation for 30 min at
37uC in hydroxyethyl-starch solution (Plasmasteril; Fresenius AG,
Bad Homburg, Germany). Granulocytes were additionally sub-
jected to a hypotonic shock for 30 seconds to remove remaining
erythrocyte contamination and both PBMCs and granulocytes
were washed with PBS. PBMCs and granulocytes were seeded at
2610
6 cells/ml and 10610
6 cells/ml, respectively, in 48-well
dishes (500 ml/well) at 37uC and 5% CO2 in RPMI 1640
containing 2% (v/v) FBS and treated with LPS (0, 0.1, 1 and
10 mg/ml). Conditioned media were harvested after 24 h of
incubation and kept at 220uC until further analysis.
Results
Chemical modification of peptidylcitrulline
Three synthetic peptides presented in Table 1 were synthesized
based on Fmoc chemistry, deprotected, purified by RP-HPLC and
analyzed by online ion trap mass spectrometry (Figure 2).
Subsequently, the peptides were chemically modified using
antipyrine and 2,3-butanedione. Ion trap mass spectrometry data
showed that the modification reaction and purification resulted in
a homogeneous product with a mass increase of 238 mass units for
all three peptides (Figure 2 and Table 1). The observed mass shift
of +238 corresponds to a chemical reaction of 2,3-butanedione
with the ureido group of citrulline to form a reactive imidazolone
derivate (Mr+50), followed by a nucleophilic addition of antipyrine
(Mr+188) to the imidazolone ring (Figure 3). Under the applied
acidic conditions this reaction mechanism is specific for citrulline
residues [25,26].
Specificity of the developed antibodies for chemically
modified peptidylcitrulline
A New Zealand white rabbit (Oryctolagus cuniculus) was
immunized with chemically modified peptide1 YAGCit*LLTK-
Figure 1. Principle of chemical modification and detection of
citrulline-containing proteins. Peptidylcitrullines are chemically
modified with antipyrine and 2,3-butanedione at low pH, followed by
dialysis against a buffer with neutral pH (Panel A) and chemically
modified citrullinated proteins are detected by sandwich ELISA (Panel
B). Coating antibodies are specific for the protein of interest and
antibodies against modified citrulline residues and peroxidase labelled
anti-rabbit antibodies are used for detection. Chemically modified
citrulline (Cit) is marked with an asterisk.
doi:10.1371/journal.pone.0028976.g001
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citrulline residues were purified from the serum by affinity
chromatography on Protein G. The specificity of antibodies for
modified peptidylcitrulline was evaluated by ELISA through
binding of the purified antibody to plates coated with either of
the 3 peptides containing modified citrulline (YAGCit*LLTK-
NH2, PIECit*TKLY-NH2 and PIECit*TYLK-NH2) or the
control unmodified peptide1 (YAGCitLLTK-NH2) (Figure 4).
The antibody reacted with all three chemically modified
citrullinated peptides but not with the unmodified control peptide.
Thus, the polyclonal antibodies were highly specific for the
chemical group of 238 mass units attached to citrulline after
chemical modification and do not react with the backbone peptide
structure.
Specificity and sensitivity of the antibody-based
detection method
In order to detect citrullinated chemokines specifically, proteins
were first chemically modified with antipyrine and 2,3-butane-
dione at low pH. The chemical modification step was followed by
dialysis against a buffer with neutral pH. 96-well plates were
coated with anti-chemokine antibodies and bound modified
chemokine was detected using the antibodies against the modified
citrulline residues (Figure 1).
To test the specificity of the two-step procedure, the defined
citrulline-containing chemokine, i.e. [Cit
5]CXCL8, was selected as
a model protein. Intact CXCL8 and the citrullinated chemokines
Figure 2. Ion trap mass spectra of purified synthetic peptides containing citrulline and chemically modified synthetic peptides.
Peptides (YAGCitLLTK-NH2 [monoisotopic Mr=920.5], PIECitTKLY-NH2 [monoisotopic Mr=1018.6], and PIECitTYLK-NH2 [monoisotopic Mr=1018.6])
were synthesized based on fluorenyl methoxycarbonyl (Fmoc) chemistry, purified using RP-HPLC, chemically modified with antipyrine and 2,3-
butanedione and repurified by RP-HPLC. The Mr of the purified synthetic peptides was determined by deconvolution of the multiple charged ions in
the raw spectra. As expected the Mr of the chemically modified synthetic peptides differs 238 mass units from the corresponding unmodified
peptide. Total ion chromatograms (TIC; black lines) and extracted ion chromatograms for the charged ions of the specific peptides (EIC; gray fill) are
shown as inserts in the experimentally determined mass spectra for (A) YAGCitLLTK-NH2 [Mr=920.6], (B) YAGCit*LLTK-NH2 [Mr=1158.6], (C)
PIECitTKLY-NH2 [Mr=1018.7], (D) PIECit*TKLY-NH2 [Mr=1256.8], (E) PIECitTYLK-NH2 [Mr=1018.7] and (F) PIECit*TYLK- NH2 [Mr=1256.8]. Citrullines
(Cit) marked with an asterisk are chemically modified.
doi:10.1371/journal.pone.0028976.g002
Table 1. Sequence and Mr of synthetic citrulline-containing
peptides, before and after chemical modification.
Synthetic
peptide Sequence Theor. Mr
a Exp. det. Mr
b
Pept1 YAGCitLLTK-NH2 920.5 920.6
Pept2 PIECitTKLY-NH2 1018.6 1018.7
Pept3 PIECitTYLK-NH2 1018.6 1018.7
Modified pept1
c YAGCit*LLTK-NH2 1158.5 1158.6
Modified pept2
c PIECit*TKLY-NH2 1256.6 1256.8
Modified pept3
c PIECit*TYLK-NH2 1256.6 1256.8
aTheoretical monoisotopic Mr.
bExperimentally determined Mr.
cCit* indicates that this citrulline was chemically modified with antipyrine and
2,3-butanedione.
doi:10.1371/journal.pone.0028976.t001
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5]CXCL8 and [Cit
9]CXCL5, as well as cell culture medium
were chemically treated with antipyrine and 2,3-butanedione at
low pH, followed by dialysis against PBS with neutral pH and
detected by ELISA using a monoclonal antibody against CXCL8
as coating antibody and a polyclonal antibody against modified
citrulline residues for detection. After chemical modification of the
samples the absorbance increased proportional with the concen-
tration of [Cit
5]CXCL8 in the sample (Figure 5, Panel B).
[Cit
9]CXCL5, non-citrullinated CXCL8 and the cell culture
medium were not detected. When no chemical modification was
introduced, none of the tested proteins including [Cit
5]CXCL8,
were detected (Figure 5, Panel A). When RPMI 1640 culture
medium with 10% FBS was spiked with [Cit
5]CXCL8, reproduc-
ible chemokine standard curves could be obtained with the newly
developed method (Figure 6, Panel A). Chemically modified
[Cit
5]CXCL8 concentrations as low as 1 ng/ml could be
measured in FBS-containing samples. To test the detection of
[Cit
5]CXCL8 in clinically relevant samples, chemokine standards
were generated in human plasma, serum and whole blood
(Figure 6, Panel B). After spiking with [Cit
5]CXCL8, whole blood
was centrifuged for 10 min at 240 g and 10 min at 7800 g to
obtain platelet-free plasma prior to the chemical treatment with
antipyrine and 2,3-butanedione. Comparable standard curves
were obtained for [Cit
5]CXCL8 in medium containing FBS, in
human plasma or serum. However, when 5 ng [Cit
5]CXCL8 was
spiked in 50 ml whole human blood, the recovery rate was
significantly lower. This is not surprising in view of the chemokine-
binding receptor DARC present on the abundant amount of red
blood cells in whole blood.
To further investigate whether citrullinated proteins could be
fully recovered in complex mixtures, cell culture supernatants from
PBMCs and granulocytes were harvested and CXCL8 concen-
trations were determined. Afterwards these supernatants were
spiked with [Cit
5]CXCL8, chemically modified and [Cit
5]CXCL8
levels measured. The percentage of [Cit
5]CXCL8 recovery was
calculated as shown in Table 2. In supernatants from PBMCs and
granulocytes 84.0610.8 and 87.1611.5% of the spiked
[Cit
5]CXCL8 amount could be recovered.
Effect of LPS on the citrullination of CXCL8 produced by
leukocytes
PBMCs and granulocytes were induced with 0, 0.1, 1 and
10 mg/ml LPS. After 24 h of incubation CXCL8 concentrations
were measured. Without LPS stimulation the amount of CXCL8
produced by PBMCs or granulocytes was below the detection limit
of the CXCL8 ELISA. As shown in Figure 7 (Panel A), levels of
CXCL8 produced by granulocytes (10610
6 cells/ml) increased
significantly when more LPS was added. Maximal CXCL8
production was already reached when PBMCs (2610
6 cells/ml)
were treated with 0.1 mg/ml LPS. Compared to PBMCs,
granulocytes secreted significantly less CXCL8 in the presence
of 0.1 mg/ml LPS. Subsequently, the [Cit
5]CXCL8 concentration
in the supernatants was determined after chemical modification
(Figure 7, Panel B). In conditioned medium of LPS-treated
PBMCs almost no CXCL8 citrullination occurred. In contrast,




PTM have an important impact on the biological activity of
cytokines and chemokines [6,7]. Chemokine quantification in
biological samples, based on standard ELISAs with chemokine
specific monoclonal antibodies, is very selective for an individual
gene product of interest, but in most cases does not allow
discrimination between different posttranslationally modified
forms of the same protein [30]. To further investigate the
biological importance of PTM the development of techniques
able to distinguish between posttranslationally modified proteins is
necessary.
A recently discovered PTM on chemokines, i.e. deimination or
citrullination, regulates the biological function of these proteins
and may also be involved in the development of diverse
pathologies like rheumatoid arthritis and multiple sclerosis [12].
Citrulline is not one of the 20 natural amino acids encoded by
DNA but is the result of a PTM induced by PADs. If proteins are
Figure 3. Chemical modification of the ureido group of a
citrulline residue by 2,3-butanedione and antipyrine. First 2,3-
butanedione (a) reacts with the ureido group of citrulline to form a
reactive imidazolone derivate (Mr+50). The first part of the reaction is
followed by a nucleophilic addition of antipyrine (b) (Mr+188) to the
imidazolone ring. The full reaction results in a total mass shift of
+238Da.
doi:10.1371/journal.pone.0028976.g003
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induce an autoimmune response. As such, anti-citrullinated
protein antibodies (ACPA) are the best diagnostic marker for
rheumatoid arthritis to date [31]. Moreover, the degradation of
myelin in the central nervous system is the hallmark of multiple
sclerosis. Reduction of the net positive charge of myelin basic
protein (MBP), through deimination, correlates strongly with
disease severity and may mediate myelin instability and loss of
compaction [15]. Therefore, it’s important to detect and quantify
citrullinated proteins in biological samples. However, citrullination
results in an increase of only one mass unit and the loss of one
positive charge. Such minor change in Mr is difficult to detect by
mass spectrometry. Furthermore, antibodies against a specific
citrullinated protein, like citrullinated antithrombin [32], were
generated. The disadvantage of such antibodies specific for one
protein is that for each application the production of novel
antibodies is needed. Moreover, we experienced in case of CXCL8
that monoclonal antibodies generated against a citrullinated
protein do not necessarily discriminate between unmodified and
citrullinated isoforms (data not shown). Recently, a chemical
method was described to chemically modify citrulline residues in
proteins. Indeed, antipyrine and 2,3-butanedione at low pH
specifically react with citrulline resulting in a modification of
238Da [25]. This allows for the identification of citrullinated
proteins by mass spectrometry [26]. However, quantification of
citrullinated proteins by mass spectrometry in biological samples is
time consuming and requires the use of complex and expensive
techniques not available in most standard laboratories. Therefore,
we developed an immunological detection method for citrullinated
proteins based on antibodies raised against chemically modified
citrulline residues. This method should allow detecting and
quantifying any citrullinated protein of choice by changing the
coating antibody used in the ELISA.
The above procedure was validated for [Cit
5]CXCL8 as a
model chemokine. Indeed only chemically modified citrullinated
CXCL8 was detected and reproducible standard curves ranging
from 1 to 50 ng/ml [Cit
5]CXCL8 were successfully generated in
culture medium containing 10% FBS, in human plasma, serum
and whole blood. The high specificity and selectivity of our
method for [Cit
5]CXCL8 is most likely explained by the high
specificity of the modification reaction for citrulline under the
strong acidic conditions used [25] and by the selective binding of
the generated antibody against the chemically modified citrulline.
It was already reported that median CXCL8 levels in synovial
fluid from patients suffering from autoimmune arthritis vary
between 1–10 ng/ml [33]. Also in cell conditioned media
containing an excess of background protein, [Cit
5]CXCL8 could
successfully be detected by the method described here with a
recovery of about 85%. The newly developed method to
specifically detect citrullinated proteins was also used to investigate
the influence of LPS on the citrullination of CXCL8 induced in
PBMCs and granulocytes. Human monocytes and neutrophils
produce CXCL8 upon stimulation with LPS [20,34,35]. PAD are
the enzymes responsible for the citrullination of proteins. The
isotype PAD4 is mainly expressed in white blood cells like
granulocytes and monocytes [36,37] and can citrullinate CXCL8
Figure 5. Specificity of the ELISA for chemically modified
citrullinated CXCL8. Chemokines [CXCL8 (¤)], citrullinated chemo-
kines [[Cit
5]CXCL8 (&) and [Cit
9]CXCL5 (N)] and RPMI 1640 medium
containing 2% FBS [control medium (x)] were chemically modified with
antipyrine and 2,3-butanedione at low pH. Subsequently, samples were
dialyzed against a buffer with neutral pH and modified citrullinated
CXCL8 ([Cit
5]CXCL8*) was detected by ELISA using anti-CXCL8 coating
antibodies and detection antibodies against modified citrulline
residues. Untreated samples (Panel A) and samples treated with
antipyrine and 2,3-butanedione (Panel B) are represented as dotted
and full lines respectively.
doi:10.1371/journal.pone.0028976.g005
Figure 4. Antibody specificity for modified peptidylcitrulline.
Binding of the antibody (absorbance at 450 nm) with 3 peptides
containing modified citrulline [YAGCit*LLTK-NH2 (¤, full line), PIE-
Cit*TKLY-NH2 (&, dotted and dashed line) and PIECit*TYLK-NH2 (m,
dashed line)] and the control unmodified peptide YAGCitLLTK-NH2 (x,
dotted line) was measured by ELISA. Citrullines (Cit) marked with an
asterisk are chemically modified.
doi:10.1371/journal.pone.0028976.g004
Quantification of Citrullinated CXCL8
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significantly higher [Cit
5]CXCL8 levels in supernatants of
granulocytes in comparison to PBMCs. Neutrophils play an
essential role in innate immunity, being the first cells recruited to
the site of infection [38]. Neutrophils can trap and kill various
bacterial, fungal and protozoal pathogens by the formation of
chromatin structures loaded with antimicrobial molecules, known
as neutrophil extracellular traps (NET) [39]. Upon stimulation
with inflammatory stimuli like LPS, the activated neutrophils will
generate the extracellular traps. Citrullination of proteins like
histones, mediates NET formation as first line of defense against
pathogens [40] and PAD4 is essential for NET-mediated
antibacterial function [41]. Our results might suggest that PAD4
in these NETs not only citrullinates histones, but also non-
structural immunomodulatory proteins such as CXCL8. Citrulli-
nation dampens the inflammatory properties of CXCL8 [8,18]
and possibly citrullination is used as a mechanism to control the
immune response.
In conclusion, a newly developed antibody-based method to
specifically detect and quantify chemically modified citrullinated proteins
is proven to be effective. This study furthermore demonstrates that
stimulated granulocytes produced significant levels of [Cit
5]CXCL8.
Figure 7. Effect of LPS on the induction of total CXCL8 and
[Cit
5]CXCL8 in PBMCs and granulocytes. PBMCs (black) and
granulocytes (white) were induced with 0, 0.1, 1 and 10 mg/ml LPS
and cell culture supernatants harvested after 24 h. CXCL8 and
[Cit
5]CXCL8 concentrations were measured by ELISA and the newly
developed antibody-based method, respectively. Results represent the
mean concentration of CXCL8 (Panel A) and [Cit
5]CXCL8 (Panel B) in ng/
ml (seven independent experiments on cells from different donors).
Statistical comparison between production levels of CXCL8 and
[Cit
5]CXCL8 was performed using the Wilcoxon matched pairs test
(* p,0.05 for comparison within a leukocyte subgroup and { p,0.05
for comparison with PBMCs induced with the same dose of LPS).
doi:10.1371/journal.pone.0028976.g007
Figure 6. ELISA standard curves for citrullinated CXCL8 in
various biological fluids. Standard curves for [Cit
5]CXCL8 were
generated in culture medium containing 10% FBS or in human plasma,
serum or whole blood. The indicated concentrations of [Cit
5]CXCL8
represent the initial concentrations spiked in the complex samples
before chemical modification and dialysis. Panel A shows two
independent standard curves for [Cit
5]CXCL8, standard 1 (#) and 2
(N), in RPMI 1640 medium containing 10% FBS. For both standards the
detection range is 1–50 ng/ml of [Cit
5]CXCL8 in the original sample. In a
second series of experiments (Panel B) standard curves for [Cit
5]CXCL8
were generated in RPMI 1640 medium containing 10% FBS (N)o ri n
human plasma (&), serum (m) or whole blood (¤) (average of two
independent experiments).
doi:10.1371/journal.pone.0028976.g006
Table 2. Chemically modified [Cit
5]CXCL8 recovery from cell
culture supernatants.
Complex sample [Cit
5]CXCL8 recovery (%) ± SEM
PBMCs 84.0610.8
Granulocytes 87.1611.5
Culture supernatants of unstimulated cells were spiked with 20 ng/ml
[Cit
5]CXCL8 before chemical modification and detection. Results represent the
mean % (6 SEM) for n=11.
doi:10.1371/journal.pone.0028976.t002
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